v3.25.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
General and administrative $ 6,090,747 $ 5,983,255
Research and development 16,125,690 11,894,315
Total operating expenses 22,216,437 17,877,570
Loss from operations (22,216,437) (17,877,570)
Interest income 742,355 765,388
Other income, net 692,869 1,150,648
NET LOSS $ (20,781,213) $ (15,961,534)
Net loss per share of common shares, basic $ (1.93) $ (1.47)
Net loss per share of common shares, diluted $ (1.93) $ (1.47)
Weighted-average number of common shares outstanding, basic 10,762,319 10,842,365
Weighted-average number of common shares outstanding, diluted 10,762,319 10,842,365

Source